Who is this course for?
This listing is marked as Advanced course in Ketamine Therapy, Clinical & Medical, Research & Science. Check the provider page for final admission or eligibility details.
This course is currently still being developed by the University of Pennsylvania School of Nursing and the Columbia University School of Social Work.
University of Pennsylvania
English
Next cohort: Sep 1, 2025
12 Weeks
Start date: September 1, 2025
Funded by a $1 million grant, the course aims to prepare social workers and nurses for the emerging field of psychedelic-assisted therapy, which is on the cusp of FDA approval. The curriculum, designed to be comprehensive and adaptable, will initially be piloted at Penn Nursing and Columbia's School of Social Work, with plans for broader dissemination. The course not only equips healthcare professionals with the skills and knowledge to administer this innovative form of treatment but also addresses the larger goal of improving access to safe and affordable mental health care.
The course is particularly timely given the current mental health crisis and the fast-track status granted to psychedelic therapies for various conditions, including depression, anxiety, and PTSD. It offers associated practicums in psychedelic research, ketamine clinics, and other clinical settings, ensuring participants receive hands-on experience. By focusing on best practices and leveraging social workers' and nurses' complementary skill sets, the course aims to meet the anticipated demand for trained practitioners in this field, thereby minimizing bottlenecks and ensuring a diverse, highly qualified workforce.
The Penn Psychedelics Collaborative at the University of Pennsylvania is a multi-school consortium of researchers, clinicians, and faculty advancing transdisciplinary psychedelic science across Penn Medicine and Penn Nursing, including clinical trials of MDMA-assisted therapy and psilocybin research. Penn researchers are also leading the development of bioethical guidelines for psychedelic-assisted therapy and community implementation frameworks.
This listing is marked as Advanced course in Ketamine Therapy, Clinical & Medical, Research & Science. Check the provider page for final admission or eligibility details.
Format: Live Classes. Time commitment: 12 Weeks.
The listed price is $5,000. Confirm the latest tuition, fees, and payment options with [object Object].
The listing includes a certificate signal. Confirm credential eligibility directly with the provider before enrolling.
The listed next cohort date is 2025-09-01.
The current listing status is Active. Use the provider website for the latest enrollment status.
By Fluence
Shares course skills and categories
Introduction to Ketamine provides clinicians with foundational knowledge of ketamine-assisted psychotherapy. It covers basic pharmacology, therapeutic mechanisms, practical administration, and key safety and ethical considerations.
By Maple Counseling
Shares course skills and categories
The course Fundamentals of Psychedelic-Assisted Psychotherapy provides an introductory overview of psychedelic therapy, elucidating its historical background, ethical implications, and the latest research in the field.
Source lists: 13.5 hours
Delivery: Online
No medicine self-experience listed
By CIIS
Same course category
The Psychedelic-Assisted Therapies and Research Certificate Program at the California Institute for Integral Studies (CIIS) Center for Psychedelic Therapies and Research (CPTR) is designed to meet the growing need for the training of skilled therapists and researchers in the field of psychedelic-ass
Next cohort: Jun 1, 2026
Source lists: Estimated 145 hours
Delivery: San Francisco, United States + Online + Portland, United States